Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonghao Jin

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|October 9, 2003
The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modelingHyun I Park, Yonghao Jin, Douglas R Hurst, et al.
The Biochemical Journal|October 10, 2003
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activitiesDouglas R Hurst, Martin A Schwartz, Mohammad A Ghaffari, et al.
Journal of Medicinal Chemistry|May 2, 2013
Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine coreYonghao Jin, Mark D Roycik, Dale B Bosco, et al.
Plos One|February 25, 2017
A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesisDale B Bosco, Mark D Roycik, Yonghao Jin, et al.
Biochemistry|January 23, 2002
Enzymatic properties of rat myelencephalon-specific proteaseSachiko I Blaber, Isobel A Scarisbrick, Matthew J Bernett, et al.
Current Topics in Medicinal Chemistry|April 14, 2006
Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseasesQing-Xiang Amy Sang, Yonghao Jin, Robert G Newcomer, et al.
Organic Letters|December 19, 2024
An Improved P(V) Thio-Oligonucleotide Synthesis PlatformMolhm Nassir, Luca Gherardi, Richard L Redman, et al.
Cancer Cell|June 20, 2017
Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC InhibitorsKun Qu, Lisa C Zaba, Ansuman T Satpathy, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|October 9, 2003
The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modelingHyun I Park, Yonghao Jin, Douglas R Hurst, et al.
The Biochemical Journal|October 10, 2003
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activitiesDouglas R Hurst, Martin A Schwartz, Mohammad A Ghaffari, et al.
Journal of Medicinal Chemistry|May 2, 2013
Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine coreYonghao Jin, Mark D Roycik, Dale B Bosco, et al.
Plos One|February 25, 2017
A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesisDale B Bosco, Mark D Roycik, Yonghao Jin, et al.
Biochemistry|January 23, 2002
Enzymatic properties of rat myelencephalon-specific proteaseSachiko I Blaber, Isobel A Scarisbrick, Matthew J Bernett, et al.
Current Topics in Medicinal Chemistry|April 14, 2006
Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseasesQing-Xiang Amy Sang, Yonghao Jin, Robert G Newcomer, et al.
Organic Letters|December 19, 2024
An Improved P(V) Thio-Oligonucleotide Synthesis PlatformMolhm Nassir, Luca Gherardi, Richard L Redman, et al.
Cancer Cell|June 20, 2017
Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC InhibitorsKun Qu, Lisa C Zaba, Ansuman T Satpathy, et al.
Pageof 2